Leukofiltration plus pathogen reduction prevents alloimmune platelet refractoriness in a dog transfusion model

Key Points Eight weekly transfusions of F-LR + pathogen-reduced donor platelets were accepted by 31 of 32 (97%) recipient dogs. Among accepting recipients, none developed lymphocyte and only 2 had platelet antibodies not associated with platelet refractoriness.